All posts tagged: LUMINA-1


Regeneron Publishes Plain Language Summary of the LUMINA-1 Phase 2 Study in FOP

On September 28, 2023, Regeneron published the results of their Phase 2 LUMINA-1 Clinical Trial of the drug garetosmab in Nature Medicine, a peer-reviewed publication. Regeneron also published clinical pharmacology results from the LUMINA-1 Trial in the Journal of Clinical Pharmacology. To support the understanding of these results by FOP families, a graphical plain language summary of […]

Read more